Table 1.
Reported prevalence of ASD in MEPS by source of case ascertainment, U.S. children ages 3–17 Years
| Calendar Years | NHIS Sample Child Core Indicator |
MEPS Condition Indicator |
NHIS Sample Child Core Indicator or MEPS Condition Indicator |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| All children (N) | Weighted Population in millionsa | Children with ASD (N) | Weighted Population in millionsa | Weighted Prevalencea (95% CI) | Children with ASD (N) | Weighted Population in millionsa | Weighted Prevalencea (95% CI) | Children with ASD (N) | Weighted Population in millionsb | Weighted Prevalenceb (95% CI) | |
| 2003–2008 | 20,795 | 61.9 (59.4–64.4) | 119 | 0.4 (0.3–0.6) | 0.7% (0.5–0.9) | 95 | 0.3 (0.3–0.5) | 0.6% (0.4–0.7) | 151 | 0.6 (0.4–0.7) | 0.9% (0.7–1.1) |
| 2009–2012 | 14,242 | 62.0 (59.0–64.9) | 146 | 0.8 (0.6–0.9) | 1.2% (0.9–1.5) | 127 | 0.7 (0.5–0.9) | 1.1% (0.8–1.4) | 196 | 1.1 (0.8–1.3) | 1.7% (1.4–2.0) |
| 2013–2015 | 10,907 | 62.4 (58.9–65.9) | 170 | 1.0 (0.7–1.2) | 1.5% (1.2–1.9) | 138 | 0.9 (0.7–1.1) | 1.5% (1.1–1.8) | 221 | 1.3 (1.0–1.6) | 2.1% (1.6–2.5) |
Source: Authors’ estimates from MEPS 2003–2015 linked to NHIS Sample Child Core 2001–2014
ASD autism spectrum disorder; CI confidence interval; MEPS Medical Expenditure Panel Survey; NHIS National Health Interview Survey
a
MEPS person-level weights adjusted for non-response to the NHIS Sample Child Core questionnaire applied and then averaged over the pooled time period